You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥易購(300937.SZ):擬設立自有控銷平台 與神鳥世紀及夏婧設金沛方藥業
格隆匯 02-24 20:22

格隆匯 2 月 24日丨藥易購(300937.SZ)公佈,為順應醫藥產業互聯網發展趨勢,在實現規模擴張的同時,豐富和優化公司品類,公司擬設立自有控銷平台。現公司擬通過貨幣出資方式與四川神鳥世紀科技有限公司(“神鳥世紀”)、自然人夏婧共同設立控股子公司—四川金沛方藥業有限公司(“金沛方藥業”)。

四川金沛方藥業有限公司註冊資本人民幣1000萬元,合作各方持股比例為四川合縱藥易購醫藥股份有限公司持股51%,四川神鳥世紀科技有限公司持股44%,夏婧5%。

沛方藥業定位於服務國內中小型連鎖、單體藥店及診所等“長尾”客户為主、全國百強連鎖為輔的目標客户羣體,採用會員制銷售模式,搭建客户、股東、工業廠家資源整合統一的控銷平台。該項投資旨在順應醫藥產業互聯網發展趨勢,在實現規模擴張的同時,通過豐富和優化公司品類,改善公司收入結構並提升盈利能力,提升公司綜合競爭能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account